Biologit is an innovative technology leader in the pharmacovigilance (PV) industry. Led by a team of PV and engineering experts, Biologit has developed technology to transform the process of literature monitoring.

The biologit MLM-AI platform is a scientific literature monitoring platform for safety surveillance that is simple to use, fully web-enabled and powered by AI. biologit MLM-AI is a validated platform built following best industry practices and ready for your regulatory needs: the feature set fully meets GVP-VI guidelines for medical literature monitoring, and role-based user management and audit trail features to ensure CFR-11 compliance. Key features include Dashboards, Automated Reporting Functionality, E2B R3 Exporting Capability, EMA MLM Reviews and Integrated Machine Translation for both abstracts and full text.

The biologit MLM-AI platform is powered by the biologit Database: a comprehensive and continuously updated repository of scientific literature, ready for compliant regulatory searches, integrating databases of global and regional reach into an easy-to-use interface. The biologit Database contains over 110,000 journals representing over 165 countries, suitable for global and local literature searches for PV.

Biologit’s latest product, biologit for Local Medical Literature Monitoring, is designed to fully automate the local literature process, including unstructured sources like websites and print journals. This innovation provides customers with in-built translation capabilities, country-level filtering and country-level workflow features.

Trusted by top pharmaceutical companies, emerging biopharma, clinical research organizations and service providers, Biologit is committed to delivering exceptional value through innovation, compliance, and quality.

Visit our website: www.biologit.com